Transforming growth factor β type II receptor (TGFβRII) mutation in gastric lymphoma without mutator phenotype

Pathology International

Volumn 48, Issue 2, 1998, Pages 134-137

  Yasumi, Kazuhiko ^a   Guo, Rong Jun ^a   Hanai, Hiroyuki ^a   Arai, Hajime ^a   Kaneko, Eizo ^a   Konno, Hiroyuki ^a   Takenoshita, Seiichi ^b   Hagiwara, Koichi ^b   Sugimura, Haruhiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Malignant lymphoma; Maltoma; Stomach; Transforming growth factor type II receptor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

AGED; ARTICLE; B CELL LYMPHOMA; CASE REPORT; CLINICAL FEATURE; FEMALE; GENE LOCUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STOMACH LYMPHOMA;

EID: 0031981196     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03882.x     Document Type: Article

References (17)

1. Igarashi H, Sugimura H, Maruyama et al. Alteration of immunoreactivity by hydrated autoclaving, microwave treatment, and simple heating of paraffin-embedded tissue sections. APMIS 1994; 102: 295-307.
2. Takenoshita S, Hagiwara K, Nagashima M et al. The genomic structure of the gene encoding the human transforming growth factor beta type II receptor (TGF-beta RII). Genomics 1996; 36: 341-344.
3. Dobashi Y, Sugimura H, Sakamoto A et al. Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas. Diagn. Mol. Pathol. 1994; 3: 9-14.
4. Shinmura K, Sugimura H, Naito Y et al. Frequent co-occurrence of mutator phenotype in synchronous, independent multiple cancers of the stomach. Carcinogenesis 1995; 16: 2989-2993.
5. Lu SL, Zhang WC, Akiyama Y et al. Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res. 1996; 56: 4595-4598.
6. Nakamura S, Akazawa K, Kinukawa N et al. Inverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma (comments). Hum. Pathol. 1996; 27: 225-233.
7. Miyazono K. TGF-beta receptors and signal transduction. Int. J. Hematol. 1997; 65: 97-104.
8. Lu SL, Akiyama Y, Nagasaki H et al. Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. Biochem. Biophys. Res. Commun. 1995; 216: 452-457.
9. Takenoshita S, Tani M, Nagashima M et al. Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers. Oncogene 1997; 14: 1255-1258.
10. Tani M, Takenoshita S, Kohno T et al. Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions. Carcinogenesis 1997; 18: 1119-1121.
11. Garrigue-Antar L, Munoz-Antonia T, Antonia SJ et al. Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells. Cancer Res. 1995; 55: 3982-3987.
12. Kadin ME, Cavaille-Coll MW, Gertz R et al. Loss of receptors for transforming growth factor beta in human T-cell malignancies. Proc. Natl Acad. Sci. USA 1994; 91: 6002-6006.
13. Chang J, Park K, Bang Y-J et al. Expression of transforming growth factor β type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res. 1997; 57: 2856-2859.
14. Lazzerschi D, Ranieri A, Mincione G et al. Human malignant thyroid tumors displayed reduced levels of transforming growth factor β receptor type II messenger RNA and protein. Cancer Res. 1997; 57: 2071-2076.
15. Munoz-Antonia T, Li X, Reiss M et al. A mutation in the transforming growth factor type II receptor gene promoter associated with loss of gene expression. Cancer Res. 1996; 56: 4831-4835.
16. Okamoto A, Jiang W, Kim SJ et al. Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line. Proc. Natl. Acad. Sci. USA 1994; 91: 11576-11580.
17. Gamberi B, Gaidano G, Parsa N et al. Microsatellite instability is rare in B-cell non-Hodgkin's lymphomas. Blood 1997; 89: 975-979.